Berkshire Sterile Manufacturing (BSM) is thrilled to announce its official rebranding to Sharp Sterile Manufacturing (SSM), marking a significant milestone in the company’s evolution. This strategic move aligns BSM with Sharp Clinical and Sharp Packaging, uniting all three entities under the Sharp brand name.
The rebranding showcases Sharp Sterile’s integration into Sharp’s network, providing clients with enhanced access to global infrastructure, expertise, and capabilities. Sharp, a global leader in commercial pharmaceutical packaging and clinical trial supply services, announced the acquisition of BSM in October 2023.
With this acquisition and rebranding, Sharp provides a fully integrated sterile injectable service offering, catering to the diverse needs of the biopharmaceutical sector. Through Sharp Sterile, Sharp Clinical, and Sharp Packaging, biopharma customers can look to Sharp for global, integrated CDMO services, including sterile drug product manufacturing, clinical trial services, commercial packaging, and distribution. By leveraging Sharp’s global infrastructure and expertise, Sharp Sterile aims to provide comprehensive solutions to its Biopharma customers worldwide.
While the company’s name may have changed, Sharp Sterile’s dedication to providing innovative, flexible, reliable, and compliant sterile filling services remains unwavering. Clients can continue to rely on Sharp Sterile’s expertise and experience in delivering high-quality small to mid-scale sterile manufacturing solutions. The company’s state-of-the-art facilities and highly skilled team will continue to provide exemplary service to meet the evolving needs of the biopharmaceutical industry.
